文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

爱尔兰2021年12月至2023年3月奥密克戎变异株优势期COVID-19疫苗接种规划对有症状和重症SARS-CoV-2感染的影响

The impact of the COVID-19 vaccination programme on symptomatic and severe SARS-CoV-2 infection during a period of Omicron variant dominance in Ireland, December 2021 to March 2023.
PubMed 文献 · Euro Surveill · 2024-01-01

该回顾性观察性疫苗影响研究利用爱尔兰2021年12月至2023年3月国家通报结局与疫苗覆盖数据及WHO疫苗有效性系统综述的估计值,估算≥50岁人群中疫苗接种规划避免的有症状就诊、急诊、住院、ICU和死亡数。结果显示该规划避免了48551例有症状就诊、9517例急诊、102160例住院、3303例ICU和15985例死亡。结论认为在奥密克戎优势期疫苗接种避免了有症状和重症COVID-19病例及死亡。

要点

  • ≥50岁人群中,疫苗接种避免48551例有症状就诊,占无疫苗时预期病例的36%。
  • 避免9517例急诊(53%)、102160例住院(81%)、3303例ICU(89%)和15985例死亡(87%)。
  • 奥密克戎优势期疫苗接种避免有症状和重症COVID-19病例,包括死亡。

核心结论

  • 在奥密克戎优势期,COVID-19疫苗接种规划避免了有症状和重症COVID-19病例,包括COVID-19死亡。

研究设计与样本

  • 本研究为回顾性观察性COVID-19疫苗影响研究,时间范围为2021年12月至2023年3月,地点为爱尔兰。
  • 研究人群为年龄≥50岁个体,使用国家通报结局与疫苗覆盖数据以及源自世界卫生组织疫苗有效性动态系统综述的疫苗有效性估计值。
  • 研究估计该年龄组COVID-19疫苗接种规划避免的结局计数和预防分数。

主要发现

  • COVID-19疫苗接种规划避免了48551例有症状COVID-19就诊至初级保健/社区检测中心,占无疫苗接种时预期病例的36%。
  • 避免了9517例急诊就诊,占预期的53%。
  • 避免了102160例住院,占预期的81%。
  • 避免了3303例ICU入住,占预期的89%。
  • 避免了15985例死亡,占预期的87%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundAs Ireland prepared for an autumn 2023 COVID-19 vaccination booster campaign, there was concern that vaccine fatigue would affect uptake, which has been abating.AimThis study aimed to quantify the direct impact of the COVID-19 vaccination programme in Ireland on averted COVID-19-related outcomes including symptomatic presentations to primary care/community testing centres, emergency department (ED) presentations, hospitalisations, intensive care unit (ICU) admissions and deaths, in individuals aged ≥ 50 years, during Omicron dominance.MethodsWe conducted a retrospective observational COVID-19 vaccine impact study in December 2021-March 2023 in Ireland. We used national data on notified outcomes and vaccine coverage, as well as vaccine effectiveness (VE) estimates, sourced from the World Health Organization's live systematic review of VE, to estimate the count and prevented fraction of outcomes in ≥ 50-year-olds averted by the COVID-19 vaccination programme in this age group.ResultsThe COVID-19 vaccination programme averted 48,551 symptomatic COVID-19 presentations to primary care/community testing centres (36% of cases expected in the absence of vaccination), 9,517 ED presentations (53% of expected), 102,160 hospitalisations (81% of expected), 3,303 ICU admissions (89% of expected) and 15,985 deaths (87% of expected).ConclusionsWhen Omicron predominated, the COVID-19 vaccination programme averted symptomatic and severe COVID-19 cases, including deaths due to COVID-19. In line with other international vaccine impact studies, these findings emphasise the benefits of COVID-19 vaccination for population health and the healthcare system and are relevant for informing COVID-19 booster vaccination programmes, pandemic preparedness and communicating the reason for and importance of COVID-19 vaccination in Ireland and internationally.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Marron L, Mateo-Urdiales A, O'Donnell J, et al. The impact of the COVID-19 vaccination programme on symptomatic and severe SARS-CoV-2 infection during a period of Omicron variant dominance in Ireland, December 2021 to March 2023. Euro Surveill. 2024. PMID: 38994604. doi:10.2807/1560-7917.ES.2024.29.28.2300697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。